Every material Form 8-K UNIVERSAL HEALTH REALTY INCOME TRUST has filed with the SEC since June 11, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Universal Health Realty Income Trust reported third-quarter 2026 net income of $4.9 million, or $.35 per diluted share, up from $4.0 million, or $.29, a year earlier. Funds from operations (FFO) rose slightly to $12.3 million, or $.88 per share, and nine-month net income rose to $15.9 million, or $1.14 per share, from $13.3 million, or $.96.
Q3 2026 net income $4.9 million ($.35 per diluted share) vs. $4.0 million ($.29) in Q3 2025
Q3 2026 FFO $12.3 million ($.88 per diluted share) vs. $12.2 million ($.88) in Q3 2025
Nine-month net income $15.9 million ($1.14 per diluted share), including a $724,000 land sale gain; adjusted net income $15.1 million ($1.09)
October 2026 sale of a Chicago parcel for $1.96 million in cash, with a Q4 2026 gain of approximately $1.90 million expected
Universal Health Realty Income Trust reported second-quarter 2026 net income of $5.9 million, or $0.43 per diluted share, up from $4.5 million, or $0.32, a year earlier. The result included a $724,000 gain on a land sale; excluding it, adjusted net income was $5.2 million, or $0.37 per share, and funds from operations rose to $12.5 million, or $0.90 per share, from $11.8 million, or $0.85.
Net income of $5.9 million, or $0.43 per diluted share, versus $4.5 million, or $0.32, in Q2 2025
Adjusted net income of $5.2 million, or $0.37 per diluted share, excluding a $724,000 gain on a land sale
Funds from operations of $12.5 million, or $0.90 per diluted share, versus $11.8 million, or $0.85, in Q2 2025
Second-quarter dividend of $0.75 per share, or $10.4 million in total, paid June 30, 2026
At its June 10, 2026 annual meeting, Universal Health Realty stockholders re-elected trustees Alan B. Miller and Robert F. McCadden to terms ending at the 2029 annual meeting, approved the nonbinding advisory vote on executive compensation, and ratified KPMG, LLP as independent auditor for fiscal 2026. The same day, the board granted restricted stock awards to four executive officers, including 6,247 shares to CEO Alan B. Miller, which vest on the second anniversary of the award.
Trustee Alan B. Miller received 9,187,560 votes for and 222,081 against; Robert F. McCadden received 8,540,716 for and 868,560 against.
Say-on-pay proposal passed with 8,955,099 votes for and 418,954 against.
KPMG, LLP ratified as auditor for the year ending December 31, 2026, with 11,525,347 votes for and 114,360 against.
Restricted stock awards: Miller 6,247 shares; Charles F. Boyle 3,631; Cheryl K. Ramagano 3,631; Karla J. Peterson 1,598.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every UNIVERSAL HEALTH REALTY INCOME TRUST filing is on SEC EDGAR ↗. 8-K briefs of other companies →